Ocumension Therapeutics·144

Jan 11, 5:33 PM ET

EyePoint Pharmaceuticals, Inc. 144

144 · Ocumension Therapeutics · Filed Jan 11, 2024

Documents

1 file
  • 144
    primary_doc.xmlPrimary